Tandem Diabetes Care Q1 2024 Financial Update

TL;DR

Tandem Diabetes Care filed its Q1 2024 10-Q, showing changes in equity accounts.

AI Summary

Tandem Diabetes Care Inc. reported its first quarter 2024 results, ending March 31, 2024. The company's financial statements show changes in common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings for the period. Specific financial figures for revenue, net income, and cash flow are not detailed in this excerpt.

Why It Matters

This filing provides a snapshot of Tandem Diabetes Care's financial health and equity structure at the end of the first quarter of 2024, which is crucial for investors assessing the company's performance and stability.

Risk Assessment

Risk Level: medium — The filing is a standard quarterly report, but the lack of specific performance metrics in this excerpt necessitates a medium risk assessment for immediate trading decisions.

Key Numbers

• 2024-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
• 2024-01-01 — Reporting Period Start Date (Indicates the beginning of the financial quarter being reported.)

Key Players & Entities

• TANDEM DIABETES CARE INC (company) — Filer
• 20240331 (date) — Reporting Period End Date
• 20240502 (date) — Filing Date
• San Diego (location) — Business Address City

FAQ

From the Filing

0001438133-24-000086.txt : 20240502 0001438133-24-000086.hdr.sgml : 20240502 20240502161219 ACCESSION NUMBER: 0001438133-24-000086 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 80 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 24908375 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 10-Q 1 tndm-20240331.htm 10-Q tndm-20240331 false 2024 Q1 0001438133 12/31 0.0289361 0.0088836 0001438133 2024-01-01 2024-03-31 0001438133 2024-04-26 xbrli:shares 0001438133 2024-03-31 iso4217:USD 0001438133 2023-12-31 iso4217:USD xbrli:shares 0001438133 2023-01-01 2023-03-31 0001438133 us-gaap:CommonStockMember 2023-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001438133 us-gaap:RetainedEarningsMember 2023-12-31 0001438133 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001438133 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001438133 us-gaap:CommonStockMember 2024-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001438133 us-gaap:RetainedEarningsMember 2024-03-31 0001438133 us-gaap:CommonStockMember 2022-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001438133 us-gaap:RetainedEarningsMember 2022-12-31 0001438133 2022-12-31 0001438133 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001438133 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001438133 us-gaap:CommonStockMember 2023-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001438133 us-gaap:RetainedEarningsMember 2023-03-31 0001438133 2023-03-31 0001438133 tndm:InsulinPumpMember srt:MinimumMember 2024-01-01 2024-03-31 0001438133 2023-01-01 2023-12-31 tndm:investment xbrli:pure 0001438133 us-gaap:ConvertibleDebtMember 2024-03-31 2024-03-31 0001438133 us-gaap:NotesReceivableMember 2024-03-31 0001438133 tndm:InsulinPumpMember 2024-01-01 2024-03-31 0001438133 tndm:SlimCartridgesAndInfusionSetsMember 2024-01-01 2024-03-31 0001438133 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001438133 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001438133 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001438133 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001438133 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001438133 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001438133 us-gaap:EmployeeStockMember 2024-01-01 2024-03-31 0001438133 us-gaap:EmployeeStockMember 2023-01-01 2023-03-31 0001438133 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-03-31 0001438133 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-03-31 0001438133 us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2024-03-31 0001438133 us-gaap:USTreasurySecuritiesMember 2024-03-31 0001438133 us-gaap:CommercialPaperMember 2024-03-31 0001438133 us-gaap:CorporateDebtSecuritiesMember 2024-03-31 0001438133 u